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Isolated pores dissected from 
human two-pore channel 2 are 
functional
Christopher J. Penny1,3, Taufiq Rahman2, Altin Sula3, Andrew J. Miles3, B. A. Wallace3 & 
Sandip Patel1
Multi-domain voltage-gated ion channels appear to have evolved through sequential rounds of 
intragenic duplication from a primordial one-domain precursor. Whereas modularity within one-domain 
symmetrical channels is established, little is known about the roles of individual regions within more 
complex asymmetrical channels where the domains have undergone substantial divergence. Here 
we isolated and characterised both of the divergent pore regions from human TPC2, a two-domain 
channel that holds a key intermediate position in the evolution of voltage-gated ion channels. In HeLa 
cells, each pore localised to the ER and caused Ca2+ depletion, whereas an ER-targeted pore mutated 
at a residue that inactivates full-length TPC2 did not. Additionally, one of the pores expressed at high 
levels in E. coli. When purified, it formed a stable, folded tetramer. Liposomes reconstituted with the 
pore supported Ca2+ and Na+ uptake that was inhibited by known blockers of full-length channels. 
Computational modelling of the pore corroborated cationic permeability and drug interaction. 
Therefore, despite divergence, both pores are constitutively active in the absence of their partners 
and retain several properties of the wild-type pore. Such symmetrical ‘pore-only’ proteins derived 
from divergent channel domains may therefore provide tractable tools for probing the functional 
architecture of complex ion channels.
Voltage-gated ion channels selective for Ca2+ (CaV), Na+ (NaV) and K+ (KV) perform a plethora of functions in 
both excitable and non-excitable cells. Mutations in these channels are the causal basis of numerous diseases, 
thereby rendering them clinically-relevant drug targets1. They are composed of four domains that form a central 
pore, with peripheral voltage sensors. Each domain consists of six transmembrane helices comprising the voltage 
sensor (S1-S4) and pore (S5-S6) regions. In KV and prokaryotic NaV, the domains are separate subunits that form 
a tetramer, resulting in symmetrical pores. In contrast, eukaryotic CaV and NaV are single polypeptide chains with 
four divergent domains, giving rise to asymmetric pores1,2. This architectural similarity suggests an evolutionary 
trajectory whereby a primordial gene encoding a one-domain channel underwent two rounds of intragenic dupli-
cation and divergence to generate the extant four-domain channels (Fig. 1A)3,4.
Two-pore channels (TPCs) are less well characterised members of the voltage-gated ion channel superfamily 
that, unusually, localise to intracellular acidic Ca2+ stores5. In animals, they are activated by the second messenger 
NAADP to release Ca2+ from the endo-lysosomal system, and are an important part of the cellular signalling 
apparatus6–8. Furthermore, TPCs are rapidly emerging as potential therapeutic targets9–11. Recent crystal struc-
tures of a plant TPC12–14 have confirmed earlier biochemical reports that they form dimers from two-domain 
(DI and DII) subunits15,16. This structural organisation identifies TPCs as a key intermediate in the evolution of 
voltage-gated ion channels from one-domain to four-domain channels (Fig. 1A). Indeed, phylogenetic analyses 
of the individual TPC domains supports this conclusion, indicating that they are substantially diverged from one 
another, and are instead more related to equivalent domains in four-domain channels17.
The modularity of the pore regions in symmetrical (often prokaryotic) channels is established18–21. For example, 
the isolated pore of a NaV from a marine bacterium forms an open, folded tetramer that is constitutively active, 
thereby supporting Na+ flux in the absence of the voltage sensor22. Similar results have been found for ‘pore-only’ 
proteins derived from other prokaryotic channels18,20,23. The functional architecture of asymmetric ion channel 
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Figure 1. Design of TPC2 pore-only proteins. (A) Proposed trajectory of evolution for one-, two- and four-domain 
voltage-gated ion channels. Dashed box highlights the ancestral pore. (B) Schematic of human TPC2 highlighting the 
two pore regions (red boxes), a residue required for channel activity (*) and N-glycosylation sites (top), and predicted 
assembly of isolated pore-only proteins derived from each domain (bottom). (C) Multiple sequence alignment of the 
pore regions of human TPC2 (HsTPC2) domain I (DI) and domain II (DII) pores with the previously characterised 
pore-only bacterial channels (NaVSp, NsVBa, NaVAe and NaVMs) along with the pore regions of the structurally-
resolved full length Na+ channels (NaVAb, NaVRh and NaVCt). For channels or pores where the structure has been 
solved, the transmembrane helices and re-entrant pore helices are highlighted in yellow and cyan, respectively. For 
HsTPC2 DII, a short turret loop was removed, denoted by ^ . (D) Predicted helical (dark blue) or ordered (light blue) 
sequences at the putative end of S6 of DI from human TPC2. Arrows indicate the last residues of the two DI pore 
constructs (M344 for the HeLa expression, and A337 for E. coli expression). For comparison, the sequences of the 
C-termini of NaVMs and NaVAe are shown, with the ends of S6 highlighted.
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pores, however, is less clear due to the inherent difficulties in analysing larger, more complex, multi-domain pro-
teins. Here, we examined whether protein dissection could be applied to the two divergent pore regions of TPCs 
as a means to probe the properties of asymmetric multi-domain proteins.
Results
Design of TPC2 pore-only proteins. We designed constructs encoding each of the pore regions of 
human TPC2 (S5-S6 and S11-S12) (Fig. 1B). To define the pore boundaries, a multiple sequence alignment was 
performed with the pore regions of previously characterised pore-only and full-length bacterial Na+ channels 
(Fig. 1C). The N-termini of TPC pores were chosen as midway between the N-termini of pore-only Na+ channel 
constructs, just upstream of the S5 regions (Fig. 1C, arrow). However, the C-terminus of TPC2 possesses little 
sequence similarity with these channels (Fig. 1C). For DI, we addressed this by performing secondary structure 
predictions which suggested an extended S6 helix (Fig. 1D). Additional disorder predictions indicated where reg-
ular secondary structure declined, thereby identifying a suitable region for truncation (Fig. 1D, arrows). For DII, 
we included the entire C-terminus. From these analyses, the pore regions for TPC2 were defined to be residues 
S212-M344 (DI pore) and L575-R752 (DII pore).
Expression of TPC2 pore-only proteins. We generated tagged constructs corresponding to each pore and 
tested their expression in both a homologous human cell line (HeLa) for cell biology studies and a heterologous 
system (E. coli) for biochemical and structural analyses.
Both TPC2 pores tagged with GFP expressed readily in Hela cells (Fig. 2A). The DII pore was resolved as a 
doublet, likely reflecting full and core N-glycosylation of the intraluminal loop between S11 and the first pore 
Figure 2. Expression of TPC2 pore-only proteins. (A,B) Western blots against pores expressed in HeLa  
(A) and E. coli (B) homogenates. Expected sizes: 42 kDa for DI pore-GFP, 48 kDa for DII pore-GFP, 16 kDa for 
hexaHis-DI pore. (C) SDS PAGE of gel filtration fractions obtained during purification of TPC2 DI pore with 
molecular weight calibration standards displayed above. (D) Western blot using a α -TPC2 antibody of purified 
TPC2 DI and NsVBa pores (expected sizes: 16 kDa for TPC2 and 15 kDa for NsVBa). (E) Mass distribution of 
the purified pore using dynamic light scattering. (F) SRCD spectrum of purified TPC2 DI pore. (G) Thermal 
denaturation of purified TPC2 DI pore monitored using SRCD spectroscopy at 222 nm.
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helix. These data suggest that the pore undergoes appropriate post-translational modification similar to the full 
length channel24. We also successfully expressed a mutant DI pore (Fig. 2A) equivalent to the inactive full length 
channel (L265P) (Fig. 1B, asterisk)25.
Large quantities of pure protein are required for biophysical and structural studies. E. coli are a useful expres-
sion system in which to achieve this, however this is notoriously challenging for human constructs, particularly 
those encoding membrane proteins. In initial trials, we partially purified a His-tagged DI pore construct that 
included an extended C-terminus, corresponding to the inter-domain loop. This was achieved through varying 
the temperature and time of protein induction, the detergent used for solubilisation and the matrix for affinity 
purification (Fig. S1A–C). Based on these findings and bioinformatics analyses of the C-terminal end of the DI 
pore (Fig. 1D), we similarly tested a series of truncated constructs (data not shown). This culminated in the effi-
cient expression of a shortened construct corresponding to residues S212-A337 (Fig. S1D) that was effectively 
solubilised with DM and purified by sequential cobalt-based affinity and size exclusion chromatography 
(Fig. 2B,C). The identity of the protein was confirmed by Western blotting using an anti-TPC2 antibody (Fig. 2D), 
and by mass spectrometry (data not shown).
The elution volume of the purified protein during size exclusion chromatography indicated an apparent molecular 
weight of ~60 kDa (Fig. 2C), consistent with a tetrameric assembly (predicted size of monomer = 15 kDa). 
However, the absence of tryptophan residues precluded more accurate quantitation using UV absorbance. We 
therefore used dynamic light scattering to estimate particle size, which indicated a single species (39% polydisper-
sity) with a hydrodynamic diameter of 6.1 nm (Fig. 2E), equivalent to the dimensions of a pore-only tetramer22. 
To probe the secondary structure of the protein, we used synchrotron radiation circular dichroism spectroscopy 
(SCRD), an advanced technique that enables detailed characterisation of proteins in detergent-containing buff-
ers26. This demonstrated a well-ordered structure comprising 59 ± 3% helix (Fig. 2F), very similar to the 58% 
helical content expected from the secondary structure prediction. Furthermore, we measured a significant and 
cooperative loss of helical secondary structure upon thermal melting, similar to that seen for tetrameric Na+ 
channel pores19,20,27 (Fig. 2G) suggesting the purified protein assembles into a stable and well-folded oligomer. 
Together, these data demonstrate that both pores of human TPC2 can be expressed in isolation to form stable 
homo-tetrameric complexes that are correctly folded and processed.
Functionality of TPC2 pore-only proteins. Next, we assessed the activity of the pores. Confocal microscopy 
revealed co-localisation of the pores with an ER (Fig. 3A) but not a lysosomal (Fig. S2) marker in HeLa cells. 
Because TPCs are Ca2+-permeable5 and the ER is a large store of Ca2+, we reasoned that the pores would deplete 
ER Ca2+ levels if they are constitutively active, similar to prokaryotic pore-only proteins18–20,22. To test this, we 
estimated ER Ca2+ content by measuring Ca2+ leaks upon blocking Ca2+ uptake with thapsigargin. These cyto-
solic Ca2+ signals were substantially reduced in cells expressing either the DI or DII pore but not the mutant DI 
pore (Fig. 3B,C), consistent with constitutive activity.
To independently measure pore functionality, we incorporated the purified DI pore into liposomes and meas-
ured radiotracer uptake (Fig. 4A). Uptake of 45Ca into reconstituted liposomes was significantly higher than 
liposomes without the pore (Fig. 4B). Additionally, diltiazem (a CaV blocker) and bupivacaine (a NaV blocker) 
both reduced 45Ca uptake by the DI pore (Fig. 4B) but had little effect on pore-free liposomes (data not shown), 
thereby attesting to specificity.
Although several studies suggest that TPCs are non-selective cation channels9,25,28, others suggest they may 
be Na+-selective29. We therefore also examined liposomal 22Na uptake and found that the DI pore was able to 
support Na+ accumulation (Fig. 4C). Further experiments compared 45Ca and 22Na uptake relative to that of the 
isolated pore of NsVBa, a non-selective ion channel from Bacillus alcalophilus30,31. As shown in the time courses 
presented in (Fig. 4D,E), the NsVBa pore supported rapid uptake of 45Ca and slower uptake of 22Na. Parallel exper-
iments with the TPC2 DI pore revealed comparable 45Ca uptake but substantially less 22Na uptake.
To rationalize these findings, we probed the properties of the DI pore computationally by generating a structural 
model using the plant TPC crystal structure as a template (Fig. 4F)12. A solvent-accessible cavity spanned the 
entire length of the putative ion conduction pathway (Fig. 4F), consistent with observed constitutive activity 
(Figs 3B,C and 4B,C). Moreover, electrostatics calculations indicated negative (i.e. favourable) potential energies 
for Ca2+ and Na+ but not Cl− at intervals within the selectivity filter (Fig. 4G,H) in accord with cation permeabil-
ity (Fig. 4B–E). We also performed molecular docking studies with diltazem and bupivacaine, which both bound 
within the pore cavity approximately midway between the selectivity filter and the bundle crossing (Fig. 4I). The 
predicted free energies of interaction were − 6.6 and − 5.6 kcal/mol, respectively, commensurate with drug block 
(Fig. 4B). In silico analyses thus support our experimental findings.
Collectively, we provide several lines of independent evidence to indicate that isolated TPC pore regions are 
capable of forming functional pores.
Discussion
In this study, we have used a variety of complementary techniques to probe the functional architecture of an 
asymmetrical two-domain voltage-gated ion channel through analyses of each of the diverged pore regions of 
human TPC2.
Previous studies using isolated pores derived from prokaryotic KV18 and NaV19,20,22, which are symmetrical 
channels, have shown that they are constitutively active. We provide two independent lines of evidence here to 
indicate that both pores of human TPC2 are also active upon isolation. In the first approach, we expressed the 
pores in Hela cells and found that they localized to the ER (Fig. 3A). Such an intracellular location precludes 
standard electrophysiological analyses that require surface expression. However, we took advantage of the fact the 
ER is the major store of Ca2+ to show that expression of the wild-type pores, but not the mutant DI pore, resulted 
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in ER Ca2+ depletion (Fig. 3B,C). Such an approach provides a novel means of inferring Ca2+ permeability of 
pores that fail to traffic to the plasma membrane.
In our second approach, we succeeded in expressing one of the pores in E. coli (Fig. 2B). This is not trivial 
for human membrane proteins. We focussed on the DI pore because it has a shorter intraluminal loop that lacks 
sites for N-glycosylation (Fig. 1B), a post translational modification not supported by E. coli. After much opti-
misation (Fig. S1), we purified sufficient quantities (Fig. 2C) to allow functional analyses which showed that the 
pore supported both Ca2+ and Na+ uptake upon reconstitution (Fig. 4). Ca2+ uptake was rapid, likely reflecting 
the presence of EGTA in the intra-liposomal solution, and comparable to the pore of NsVBa (Fig. 4D). NsVBa is 
non-selective channel with a PCa/PNa of ~1.530 Because Na+ uptake was more modest for the DI pore relative to 
NsVBa (Fig. 4E), we speculate that the DI pore may be more permeable to Ca2+ than Na+, results supported by our 
electrostatics calculations (Fig. 4F–H). However, direct electrophysiological analysis is required to establish this. 
Such an estimate is inconsistent with marked Na+ selectivity reported for recombinant full-length TPC2 in some 
studies29, and is instead more comparable to that of endogenous TPC2 (PCa/PNa = 0.57–0.86)28.
The wild-type TPC pore is a dimer comprising alternating pore domains12–14. The domains of TPCs have 
undergone substantial divergence such that they appear to be more related to equivalent domains in four-domain 
channels than to one another17. Yet as shown here dissecting symmetrical pore-only proteins from either domain 
creates stable structures that retain essential elements of pore functionality. We liken homomeric TPC pores to 
ancestral TPCs formed upon intragenic duplication but prior to divergence (Fig. 1A). We speculate that the con-
tribution of DII within the wild-type pore can be substituted by DI, as exemplified by both the structural integrity 
(Fig. 2E–G), functionality and drug block (Fig. 4B–E) of the DI pore-only protein. Equally, the contribution of 
the DI can substituted by DII as exemplified by the functionality of the DII pore (Fig. 3B,C), although further 
biophysical, biochemical and pharmacological characterisations will be required for confirmation. This suggests 
that there is a certain degree of functional and architectural ‘redundancy’ in the pore make-up of multi-domain 
voltage-gated ion channels i.e either pore domain can assemble and function without the other. This parallels 
Figure 3. Functionality of TPC2 pore-only proteins in live cells. (A) Confocal images of HeLa cells co-
expressing an ER marker (DsRed2-ER, red) and the indicated GFP-tagged pore (green). Nuclei (blue) were 
stained with DAPI. Scale bar 10 μ m. Co-localisation calculated between arrowheads (below). (B) Cytosolic Ca2+ 
levels of individual HeLa cells expressing the indicated pore-only construct, stimulated with 1 μ M thapsigargin 
in the absence of extracellular Ca2+. (C) Bar graphs quantifying signal magnitudes (n = 3–4).
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the observed functionality of a chimeric KV from Drosophila melanogaster in which the pore region (S5-S6) of 
the symmetrical Shaker channel is replaced with a pore region (M1-M2) of asymmetric KCNK032. The latter is 
a member of the two-pore domain K+ family (K2P) that lack canonical voltage sensors but, like TPCs, have two 
pore domains33. The resulting symmetrical pore derived from an asymmetrical channel in the chimera (although 
not isolated) is thus conceptually similar to our TPC2 pore-only constructs.
Successful purification of a functional, stably folded, tetrameric TPC2 pore provides a suitable preparation 
for structural investigation of human TPCs, for which atomic information is currently lacking. Although its 
homomeric nature clearly distinguishes it from the wild- type pore (Fig. 1B), symmetrical pores are provid-
ing significant insight into the properties of their asymmetric counterparts. For example, prokaryotic NaVs are 
homotetramers that nonetheless bind and are regulated by the same Na+ channel antagonists that target asym-
metric eukaryotic NaV34. Moreover, a mutant prokaryotic NaV, into which Ca2+ selectivity has been engineered 
Figure 4. Functional reconstitution of a purified TPC2 pore-only protein. (A) Schematic depicting the 
radiotracer uptake method for assessing pore functionality. (B,C) Accumulation of 45Ca (B) or 22Na  
(C) following a 60 min incubation with control liposomes or liposomes incorporating the purified DI pore of 
TPC2 (n = 6–9; *represents p < 0.05, as assessed by unpaired Student’s t-test). Experiments were performed in 
the absence and presence of 100 μ M diltiazem or 1 mM bupivacaine as indicated (n = 3–4). (D,E) Time course 
for uptake of 45Ca (D) or 22Na (E) by the TPC2 DI pore relative to pore of NsVBa. Data (n = 3–4) are normalised 
to the NsVBa signal at t = 60 minutes. (F) Homology model of DI pore (grey), displaying the solvent-accessible 
putative ion conduction pathway as a surface plot. Blue indicates diameters > 5 Å, and green diameters between 
2.3 and 5 Å. (G,H) Calculated electrostatic potential energies for Ca2+, Na+ and Cl− (H) at the highlighted 
points throughout the selectivity filter of the DI pore (G). Blue spheres reflect the diameter of Ca2+ ions used 
within the calculation. (I) Zoomed view of diltiazem (cyan) and bupivacaine (magenta) docked to the structural 
model in (F), with a single monomer removed for clarity. Residues (full length numbering) predicted to form 
hydrogen bonds with the drugs are highlighted in yellow.
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(‘CavAb’) is targeted by eukaryotic CaV antagonists35. Our finding that Ca2+ uptake by the DI pore is sensitive 
to both Na+ and Ca2+ channel antagonists (Fig. 4B), similar to full-length TPCs17, suggests that essential phar-
macological features are also preserved upon simplification of the TPC pore. In support, our docking analyses 
predict a drug binding site centred within the pore cavity comprising asparagine residues in S6 from multiple 
chains (N305 in full length TPC2) (Fig. 4I). This region corresponds to our previous in silico study using a 
wild-type TPC pore17 and the crystallographic mapping of a local anaesthetic within the pore of a prokaryotic 
Nav34. Notably, mutagenesis of conserved asparagines in domain I and III of eukaryotic NsV reduces sensitivity to 
local anaesthetics, suggesting a common binding site36,37. Thus, our reductionist approach might well be of rele-
vance not only to two- but perhaps even four-domain channels, which currently represent a formidable challenge 
to structure-function analyses.
Methods
Bioinformatics. Multiple sequence alignments were carried out using ClustalOmega38. Sequences used, 
with accession/PDB codes in parentheses, were human TPC2 (AAH63008)6, NsVSp (AAR26729)19,20, NsVBa 
(AFV25941)30,31, NsVAe (4LTO)20, NsVMs (3ZJZ)22, NsVAb (4EKW)39, NsVRh (4DXW)40 and NsVCt (4BGN)41. 
Secondary structure predictions were performed using PSIPRED42 and JPred43. Disorder predictions were per-
formed using PrDOS44, DisEMBL45 and DISOPRED46.
Plasmids. For expression in HeLa cells, nucleotide sequences corresponding to the pore regions of TPC2 
were amplified by PCR using IMAGE Clone 5214862 (BC063008) as the template and domain-specific primers 
(Table S1). The products were inserted in frame into EcoRI/XhoI sites of pCS2 + containing the coding sequence 
of GFP to generate C-terminally-tagged constructs. The DI pore mutant was generated by site-directed mutagen-
esis using primers previously used to introduce the L265P mutant in the full length channel25 (Table S1).
For expression in E. coli cells, nucleotide sequences corresponding to codon-optimised pore regions were 
synthesised by MWG Operon and inserted between the NdeI/BamHI sites of pET15b to generate N-terminally 
hexa-histidine-tagged constructs. The initial codon-optimised construct spanned S212-Q418 and incorporated 
the DI-DII linker. After initial expression trials (Fig. S1), a stop codon was introduced at the residue equivalent to 
A337 in the full length channel by site-directed mutagenesis using the primers described in Table S1.
DNA sequencing confirmed the correct sequences for all clones. pDsRed2-ER was obtained from Clontech 
Laboratories. The plasmid encoding LAMP1-mRFP was described previously47.
Human cell culture and preparation of cell lysates. HeLa cells were cultured in DMEM Glutamax I 
(GIBCO) (a Ca2+-containing medium) supplemented with 10% fetal bovine serum (GIBCO), 100 U/ml penicillin 
and 100 μ g/ml streptomycin (GIBCO) at 37 °C in a 5% CO2 humidified atmosphere. For transfection, cells were 
plated onto sterile 10 mm coverslips coated with 20 μ g/ml poly-L lysine (Sigma) or 6-well tissue culture plates and 
transiently transfected with Lipofectamine®2000 (Invitrogen), as per the manufacturer’s protocol. Cell viability 
was reduced in cultures expressing either the DI and DII pores (data not shown).
To prepare lysates for Western blotting, cells were harvested by scraping, and then lysed in Ripa buffer 
(150 mM NaCl, 50 mM Tris, 0.5% (w/v) sodium deoxycholic acid, 0.1% (v/v) sodium dodecyl sulphate, 1% (v/v) 
Triton X-100, pH7.4), supplemented with EDTA-free protease inhibitors (Roche) and HaltTM phosphatase inhib-
itor cocktail (Thermo Scientific) for 30 min on ice. Samples were centrifuged at 15,000 g at 4 °C for 15 min and the 
resulting supernatants stored at − 20 °C. Protein concentrations were calculated using a bicinchoninic acid assay, 
calibrated to bovine serum albumin protein standards.
Bacterial cell culture and protein purification. The DI pore constructs were overexpressed by the addition 
of 0.5 mM isopropylthiogalactoside to C41(DE3) E. coli cells grown in lysogeny broth containing 100 μ g/ml ampi-
cillin at an A600 of 0.7–0.9. Cells were cultured for a further 3 h at 37 °C or 18 hr at 22 °C (for expression trials), pel-
leted by centrifugation and stored at − 80 °C. Cell pellets were resuspended at 4 ml/g of cells in lysis buffer (25 mM 
Tris, 300 mM NaCl, 0.2 mM phenylmethylsulfonyl fluoride (PMSF), 1 μ g/ml DNAse I (Life Technologies), 2.5 mM 
MgSO4, pH7.4 supplemented with EDTA-free protease inhibitor (Roche)) and lysed by pressure homogenisation 
with an Avestin EmylsiFlex-C5. The resulting homogenate was centrifuged at 10000 g for 30 mins at 4 °C to pellet 
unlysed cells and inclusion bodies. The supernatant was then centrifuged at 200000 g for 2.5 hours at 4 °C to pellet 
the membrane fraction. The membrane pellets were resuspended in solubilisation buffer (25 mM Tris, 500 mM 
NaCl, 0.2 mM PMSF, pH7.4, supplemented with EDTA-free protease inhibitors and an excess of detergent) 
and incubated for 2 h at 4 °C. The detergents used (with % (w/v) used for solubilisation in parentheses; all from 
Anatrace) were: n-decyl β -D-maltopyranoside (DM, 0.87%) and in initial expression trials, lauryldimethylamine 
oxide (LDAO, 0.23%); n-dodecyl β -D-maltopyranoside (DDM, 1%) and Cymal-5 (1.2%). Unsolubilised material 
was removed by centrifugation at 20000 g for 30 mins at 4 °C. To bind His-tagged proteins, the soluble fraction was 
incubated with either Ni-NTA (Qiagen) or TALON (Clontech) affinity resin in the presence of 20 mM imidazole 
to reduce non-specific binding. After ~16 hours at 4 °C, the protein-bound resin bed was washed with 80x bed 
volume of buffer A (25 mM Tris, 500 mM NaCl, 0.174% (w/v) DM, pH7.4) containing 20 mM imidazole. Bound 
protein was eluted with 5x bed volume of buffer A containing 500 mM imidazole. The sample was then concen-
trated using a 50 kDa-cutoff Amicon Ultracentrifugal filter, diluted with buffer A and re-concentrated to remove 
imidazole.
For size exclusion chromatography, the concentrated sample (~100 μ l) was loaded onto a Superdex 200 10/300 
GL gel filtration column (GE Healthcare), connected to an AKTA FPLC and eluted with buffer A at 0.5 ml/min. The 
pureified protein (~300 μ g from a 45 l culture) was concentrated to ~10 mg/ml, flash-frozen in liquid nitrogen and 
stored at − 80 °C. Gel filtration columns were calibrated using protein standards (Sigma). The protein identity was 
confirmed by mass spectrometry at the Protein and Nucleic Acid Chemistry Facility, Cambridge University, UK.
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The NsVBa pore (A138-Q265) was expressed and purified as previously described31.
SDS PAGE and Western blotting. HeLa cell lysates (15 μ g), raw and solubilised E. coli membranes, affinity 
and size exclusion chromatography fractions, or purified pore proteins (2.2 ng) were separated on NuPAGE 
Novex 4–12% BisTris SDS gels (Life Technologies) and where indicated, stained with Instant Blue coomassie 
stain (Expedeon).
For Western blotting, proteins were transferred to PVDF (BioRad or iBlot, Life Technologies) membranes 
according to standard procedures. The primary antibodies used were anti-GFP (rabbit polyclonal α -GFP, 
A11122 Life Technologies, 1 in 1000) and anti-TPC2 (rabbit polyclonal α -TPC2, Eurogentec custom anti-
body, 1 in 1000)24. Blots were developed using a secondary antibody (goat α -rabbit IgG/horseradish peroxidase 
(HRP) conjugate, 1706515 BioRad, 1 in 2000) and the ECL Prime Western Blotting System (GE Healthcare). All 
antibodies were incubated for 1 hr at room temperature. His-tagged proteins were detected using a monoclo-
nal α -poly-histidine/alkaline phosphatase conjugate antibody (mouse, A5588 Sigma, 1 in 2000, 2 hrs at room 
temperature). Blots were developed using SIGMAFAST BCIP/NBT tablets (Sigma), as per the manufacturer’s 
instructions.
Dynamic light scattering. Dynamic light scattering experiments were carried out using a pUNk instrument 
(Unchained Labs) according the manufacturer’s instructions. Purified protein (5 μ l at 5 mg/ml) was loaded into 
a blade cell. Using an unbiased approach, the optimal traces from 10 runs were combined to calculate hydrody-
namic diameters and polydispersity values.
Synchrotron radiation circular dichroism (SRCD) spectroscopy. SRCD spectra were measured at the 
DISCO beamline at the Soleil Synchrotron (France). Data were collected in a 0.1 nm path-length demountable 
Suprasil cell (Hellman Ltd, UK) at 15 °C from 270 nm to 180 nm, using a 1 nm step size and a dwell time of 1.2 sec. 
Spectra (obtained in triplicate) were corrected for baselines using protein-free buffer, calibrated using camphor 
sulphonic acid, and scaled to units of delta epsilon using a mean residue weight value of 113.1. Processing was 
undertaken using the CDtools software48. Resulting spectra were analysed for secondary structure content using 
the DichroWeb analysis server49 with the CONTIN algorithm and the SMP180 reference dataset specifically 
designed for the analysis of membrane proteins50. Thermal melt experiments were performed between 15 °C and 
95 °C by obtaining triplicate measurements at 222 nm, following 5 °C step increments and an equilibration period 
of 5 min.
Confocal microscopy. Cells were fixed 4% (w/v) paraformaldehyde (VWR) for 10 min at room temperature 
and confocal images were captured using the LSM510 confocal scanner attached to an inverted Axiovert 200 M 
microscope (Zeiss) fitted with a Plan-Apochromat 63x water immersion objective. The excitation wavelengths (ex) 
and emission filters (em) were as follows: DAPI, ex 364 nm/em 385–470 nm; GFP, ex 488 nm/em 505–530 nm; RFP, 
ex 543 nm/em 560–615 nm. Zeiss ZEN2009 and ImageJ were used to acquire and present the images.
Live cell Ca2+ imaging. Cytosolic Ca2+ concentration was measured using the ratiometric dye, Fura-2. 
HeLa cells were incubated for 1 hour with 2.5 μ M Fura-2-AM (Life Technologies) and 0.005% (v/v) pluronic 
(Life Technologies) in HEPES-buffered saline (HBS; 1.25 mM KH2PO4, 2 mM CaCl2, 2 mM MgSO4, 3 mM KCl, 
156 mM NaCl, 10 mM D-glucose and 10 mM NaHEPES, pH 7.4). Cells were washed in HBS and mounted in a 
1 ml imaging chamber. Fluorescence images were captured with a cooled coupled device camera (TILL photonics) 
attached to an Olympus IX71 inverted fluorescence microscope, fitted with a 20x objective and a monochroma-
tor light source. Fura-2 was excited at 340/380 nm and emission captured using a 440 nm long-pass filter at 3 s 
intervals. Following base-line recording in HBS, cells were washed into Ca2+ free HBS (CaCl2 replaced with 1 mM 
EGTA) and stimulated with 1 μ M thapsigargin (Merck). Transfected cells were identified prior to Ca2+ measure-
ments by excitation at 488 nm, capturing emission with a 515 nm long-pass filter.
Radiotracer uptake. Radiotracer uptake experiments were carried out based on previously validated protocols19,51. 
With this method, high concentrations of intraliposomal cations generate electrochemical gradients that drive 
extraliposomal radiotracer accumulation.
A 3:1 mixture of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE) and 1-palmitoyl-
2-oleoyl-sn-glycero-3-phospho-(1′ -rac-glycerol) (POPG, both from Avanti Polar Lipids) was sonicated in 
intraliposomal buffer supplemented with 37 mM CHAPS (Anatrace). The mixture was incubated at room 
temperature for 2 hours prior to addition of purified pore proteins (20 μ g protein/mg lipid). Following a fur-
ther 20 minute incubation, proteoliposomes were recovered by sequential centrifugation (1000 g, 20 s) through 
partially dehydrated Sephadex G50 columns (1 ml) pre-soaked in intra- and extra-liposomal buffer. The 
intraliposomal buffer was composed of 10 mM HEPES, 4 mM NMDG, 0.5 mM EGTA and either 300 mM BaCl2 
(for 45Ca experiments) or 450 mM NaCl (for 22Na experiments). The extraliposomal buffers contained 400 mM 
D-sorbitol, 10 mM HEPES, 4 mM NMDG, with 0.5 mM EGTA for 22Na experiments only. All buffers were at pH7.4.
To initiate uptake, proteoliposomes were diluted into extraliposomal buffer supplemented with 2 μ Ci/ml 45Ca 
(specific activity: 25.6 mCi/mg) or 0.5 μ Ci/ml 22Na (specific activity: 633.8 mCi/mg) (both from Perkin Elmer). 
In some experiments, the extraliposomal buffer also contained either 100 μ M diltiazem or 1 mM bupivacaine 
(both from Sigma). Unincorporated radiotracer was removed by passing triplicate samples (60 μ l) at the stated 
time points, through NMDG-charged DOWEX cation exchange columns (0.5 ml) pre-soaked in 400 mM sorbitol 
(Sigma). Samples were eluted with 1 ml of 400 mM sorbitol and radioactivity determined by liquid scintillation 
counting. To reduce non-specific binding, the DOWEX columns were sequentially washed with 400 mM sorbitol 
containing 5 mg/ml BSA and then 10 mg/ml POPE/POPG prior to use.
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Homology modelling. Homology modelling of the human TPC2 DI pore monomer was carried out using 
the Phyre2 server52 with the crystal structure of AtTPC1 (pdb: 5E1J) as a template12, according to the align-
ment shown in Fig. S3. Residues D245-R251 in the putative turret loop between S5 and the first pore helix were 
excluded due to lack of suitable template. Energy minimisations were carried out with GalaxyRefine53, and the 
model with the lowest MolProbity score54 was assembled into a tetramer by structural alignment with AtTPC1, 
and further refined using GalaxyRefineComplex53. The pore interior cavity was visualised using HOLE55.
Electrostatics calculations. Electrostatic potential energy calculations using the Poisson-Boltzmann equation 
were carried out using APBSmem56, as described previously57. The homology model of the DI pore was aligned 
along the z-axis and centred at 0,0,0. Partial charges and atomic radii were assigned to the homology model by 
PDB2PQR58 using the CHARMM parameter set59. A 300 × 300 × 300 Å3 map with 97 × 97 × 97 gridpoints was 
used within APBSmem. The 40 Å-thick hydrophobic membrane slab ranged between − 25 Å and 15 Å in the 
z-axis, with a water-containing exclusion of 18 Å through the pore. The dielectric constants for water, membrane 
and protein were 80, 2 and 2, respectively, whilst the ionic strength was set at 0.1 M with columbic charges of ± 
1 and radius of 2 Å. The water probe radius was 1.4 Å, and the temperature was 298.15 K. The charge and surface 
models were Spl2 and Mol, respectively. Energy calculations were made for Ca2+, Na+ and Cl− (with final Born 
radii of 1.73 Å, 1.68 Å and 1.88 Å, respectively) at 3 Å intervals along the z-axis.
Docking. Structures of diltiazem and bupivacaine were downloaded from the ZINC database (http://zinc.
docking.org/)60 and were docked to the structural model using Autodock4.261 as previously described17,62. 
Docking was performed in a blind fashion using a 50 × 50 × 50 Å grid with 0.375 Å spacing. 100 docking runs 
were carried out using a Lamarkian Genetic Algorithm63 using default parameters. The top ranked pose for each 
compound was selected for presentation. Ligand-protein interactions were predicted using LigPlot+ (http://www.
ebi.ac.uk/thornton-srv/software/LigPlus)64.
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